Placebo Beat Risankizumab in Adults With Severe Asthma Placebo Beat Risankizumab in Adults With Severe Asthma

Risankizumab, a humanized, monoclonal antibody approved for the treatment of moderate to severe psoriasis, underperformed placebo in adults with severe asthma.Medscape Medical News

Source: Medscape Medical News Headlines - October 27, 2021 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news